avril 13, 2018
Biocellvia gears up for NASH

Biocellvia has begun its NASH assay development

Approximately 20% of the United States population have non-alcoholic fatty liver, and the number of people affected is increasing. In Europe, the population is more and […]

We are working hard on our new website!
Unfortunately, we haven't yet found a technology as fast as Biocellvia's .
Please be kind to our old design and come say hello to the new one when it is up and running.